Related Experiment Video
Updated: May 31, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Risk factors and outcomes for patients with vascular disease and serious bleeding events
Mark J Alberts1, Deepak L Bhatt, Sidney C Smith
1Department of Neurology, Northwestern University Feinberg School of Medicine, 710N Lake Shore Drive, Room 1420, Chicago, IL 60611, USA. m-alberts@northwestern.edu
Insights
Serious bleeding events in patients with atherosclerotic vascular disease are uncommon but linked to higher risks of major vascular events. Key predictors of bleeding include age, smoking, and certain medications.
Area of Science:
- Cardiovascular Medicine
- Clinical Epidemiology
Background:
- Atherosclerotic vascular disease (ASVD) affects a large population, necessitating understanding of associated risks.
- Serious bleeding is a known complication, but its precise incidence and impact in ASVD patients require further elucidation.
Purpose of the Study:
- To investigate the incidence and outcomes of serious bleeding events in a large cohort of patients with ASVD or risk factors.
- To identify predictors of serious bleeding and its association with subsequent major vascular events.
Main Methods:
- Prospective observational study of 68,375 outpatients with prior ischemic vascular events or multiple atherosclerotic risk factors.
- Follow-up data for 64,977 patients, with main outcome measures including rates of serious bleeding and 1-year outcomes.
Main Results:
- The 1-year incidence of serious hemorrhage was 0.92% (cerebral hemorrhage 0.11%).
- Patients with symptomatic ASVD had higher hemorrhage rates (1.0%) than those with risk factors only (0.59%).
- Predictors included age, smoking, hypertension, diabetes, heart failure, antithrombotics, and polyvascular disease. Anticoagulant and dual antiplatelet/anticoagulant use significantly increased bleeding risk.
- Serious bleeding (excluding cerebral) was associated with a >3-fold increased risk of major vascular outcomes (myocardial infarction, stroke, vascular death).
Conclusions:
- Serious bleeding complications in ASVD patients are relatively rare but carry significant implications due to the large at-risk population.
- Bleeding predictors overlap with those for ischemic events, highlighting shared risk factors.
- Experiencing a serious bleed substantially elevates the risk of major vascular events, underscoring the need for careful risk-benefit assessment in treatment strategies.
Objective:
To determine the risk and outcomes of serious bleeding events in patients with atherosclerotic vascular disease or risk factors.
Methods:
68 375 outpatients with prior ischaemic vascular events or multiple atherosclerotic risk factors were followed in this prospective observational study; 64 977 had 1-year follow-up data. Main outcome measures were rates of serious bleeding events and 1-year outcomes for patients with and without serious bleeding events.
Results:
The 1-year rate of serious haemorrhage was 0.92%, with a cerebral haemorrhage rate of 0.11%. Patients with symptomatic vascular disease had a haemorrhage rate of 1.0%, compared with 0.59% in those with risk factors only. Risk factors for serious bleeding included age, smoking, hypertension, diabetes, congestive heart failure, use of antithrombotics and polyvascular disease. Bleeding risk increased with the use of anticoagulants (OR 1.99, 95% CI 1.38 to 2.86, p<0.001) or antiplatelet agents combined with anticoagulants (OR 2.54, 95% CI 1.74 to 3.71, p<0.001). By logistic regression analysis, patients with a serious bleed (excluding cerebral haemorrhage) had a more than threefold increased risk (HR 3.25, 95% CI 2.58 to 4.10, p<0.0001) of a significant vascular outcome (myocardial infarction, stroke, vascular death) compared with patients without a serious bleed.
Conclusions:
Serious bleeding complications were relatively rare, but significant considering the large population at risk. Predictors of increased bleeding were similar to the risk factors for ischaemic events. Patients who experienced a serious bleed had a significantly higher rate of major vascular events.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology